Free

‘HEROIN ON TRIAL’: Heroin-Assisted Treatment in the UK

Event Information

Share this event

Date and Time

Location

Location

Bush House, The Strand, King’s College London, 30 Aldwych, WC2B 4BG

London

WC2B 4BG

United Kingdom

View Map

Event description

Description

Session I (10.15 – 11.30am) Chair: Susanne MacGregor

(i) The ‘Old British System’ - overview and examination of long-term patients

  • Uncertainty and crisis within the ‘British System’ drug clinics (Martin Mitcheson).
  • Examination of Manchester long-term injectable patients (Louise Sell).
  • Examination of patients on long-term heroin prescribing (Nicola Metrebian #1).
  • Deaths whilst on pharmaceutical heroin: look-back on the ‘Old British System’ and also at the new supervised injectable heroin clinics (Basak Tas).

Session II (11.45 – 1.00pm) Chair:

(ii) The new system of ‘Heroin-Assisted Treatment’ and considerations in the UK

  • The development and operation of supervised heroin treatment at local and national level (Ambros Uchtenhagen).
  • The 2009 DH review of heroin prescribing: preserving ongoing care where benefit produced while recognising strong evidence for new HAT (Eilish Gilvarry).
  • The clinical detail of working with supervised heroin treatment team in the UK (Rob VanderWaal).
  • Working on recovery with patients in the supervised heroin treatment clinic (Tim Leighton).

Session III (2.00 – 3.15pm) Chair: Eilish Gilvarry and Ed Day

(iii) The UK-RIOTT trial and its findings

  • Overview of the RIOTT trial and its findings (John Strang).
  • 3-year outcome after the RIOTT trial (Nicola Metrebian #2).
  • The patient perspective: review of qualitative studies (James Bell).
  • Health economic analysis of the RIOTT trial (Sarah Byford).
  • Understanding overdose after pharmaceutical heroin: experimental testing (John Strang #2).

Session IV (3.30 – 4.45pm) Chair: Owen Bowden-Jones

(iv) Heroin as treatment - current challenges and options

  • Supervised heroin prescribing and the possible need for this treatment in the US: the RAND 2018 review of evidence (Beau Kilmer).
  • The 2017 ‘Orange Guidelines’ consideration of supervised heroin prescribing (Brian Kidd).
  • The drug-crime link: supervised heroin-prescribing to break the vicious circle (TBC).
  • Supervised heroin treatment as part of Glasgow comprehensive care: what treatment model and what research opportunity? (Carole Hunter).
  • Concluding remarks - Tackling the failure to deliver: the need for better science-policy-practice dialogue (John Strang).





This event is supported by the Society for the Study of Addiction and by the NIHR Biomedical Research Centre (BRC) for Mental Health (King's College London and South London & Maudsley Mental Health Foundation Trust.

Share with friends

Date and Time

Location

Bush House, The Strand, King’s College London, 30 Aldwych, WC2B 4BG

London

WC2B 4BG

United Kingdom

View Map

Save This Event

Event Saved